deltatrials

Leukemia Trials in Boston, United States

Conditions / Leukemia / Boston, United States

Clinical trials for Leukemia investigate a range of treatment strategies and patient populations.

162 total trials for this combination

Showing top 10 of 162 trials

Trials

NCT ID Title Status Phase
NCT00006462 Gemcitabine in Treating Children With Relapsed or Refractory Acute Lymphoblastic Leukemia or Acute Myelogenous Leukemia COMPLETED PHASE2
NCT02192333 Survivorship Care in Reducing Symptoms in Young Adult Cancer Survivors COMPLETED NA
NCT00736749 Long-Term Follow-Up of Patients Who Have Participated in Children's Oncology Group Studies RECRUITING
NCT00417040 Collection of Patient-Reported Symptoms and Performance Status Via the Internet COMPLETED NA
NCT00004932 STI571 in Treating Patients With Recurrent Leukemia COMPLETED PHASE1
NCT06578247 Quizartinib or Placebo Plus Chemotherapy in Newly Diagnosed Patients With FLT3-ITD Negative AML RECRUITING
NCT00003593 Chemotherapy in Treating Children With Down Syndrome and Myeloproliferative Disorder, Acute Myelogenous Leukemia, or Myelodysplastic Syndrome COMPLETED PHASE3
NCT00898755 Collecting and Storing Tissue From Young Patients With Cancer COMPLETED
NCT00003178 Chemotherapy in Treating Children With Recurrent Acute Myeloid Leukemia COMPLETED PHASE2
NCT00021242 Docetaxel in Treating Children With Relapsed or Refractory Acute Lymphoblastic or Acute Myeloid Leukemia COMPLETED PHASE2

Related Pages